ONE YEAR FOLLOW UP IN THREE PHASE IB/IIA CLINCIAL TRIALS OF EX VIVO EXPANDED ALLOGENEIC BONE MARROW DERIVED MESENCHYMAL STEM CELLS FOR THE TREATMENT OF FISTULIZING CROHN'S DISEASE

被引：0
|
作者：
Lightner, Amy L.
Pineiro, Ana Otero
Reese, Jane
Ream, Justin
Nachand, Douglas
Adams, Ashley
VanDenBossche, Alexandra
Dadgar, Neda
Hull, Tracy L.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
325
引用
收藏
页码：S1470 / S1471
页数：2
相关论文
共 49 条
  • [21] Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up
    Sander F. Rodrigo
    Jan van Ramshorst
    Georgette E. Hoogslag
    Helèn Boden
    Matthijs A. Velders
    Suzanne C. Cannegieter
    Helene Roelofs
    Imad Al Younis
    Petra Dibbets-Schneider
    Willem E. Fibbe
    Jaap Jan Zwaginga
    Jeroen J. Bax
    Martin J. Schalij
    Saskia L. Beeres
    Douwe E. Atsma
    Journal of Cardiovascular Translational Research, 2013, 6 : 816 - 825
  • [22] Adult allogenic bone marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulas in the setting of Crohn's disease
    Otero-Pineiro, A. M.
    Lightner, A. L.
    TECHNIQUES IN COLOPROCTOLOGY, 2022, 26 (10) : 831 - 832
  • [23] Adult allogenic bone marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulas in the setting of Crohn’s disease
    A. M. Otero-Piñeiro
    A. L. Lightner
    Techniques in Coloproctology, 2022, 26 : 831 - 832
  • [24] A Phase IB/IIA study of remestemcel-L, an allogeneic bone marrow derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: An interim analysis
    Lightner, A.
    Dadgar, N.
    Fulmer, C.
    Ream, J.
    Nachand, D.
    Steele, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I398 - I399
  • [25] A PHASE IB/IIA STUDY OF REMESTEMCE-L, AN ALLOGENEIC BONE MARROW DERIVED MESENCHYMAL STEM CELL PRODUCT, FOR THE TREATMENT OF MEDICALLY REFRACTORY ULCERATIVE COLITIS: AN INTERIM ANALYSIS
    Lightner, Amy L.
    Dadgar, Neda
    Fulmer, Clifton G.
    Ream, Justin
    Nachand, Douglas
    Steele, Scott
    GASTROENTEROLOGY, 2022, 162 (07) : S1325 - S1326
  • [26] A Phase IB/IIA study of remestemcel-L, an allogeneic bone marrow derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: An interim analysis
    Lightner, A.
    Dadgar, N.
    Fulmer, C.
    Ream, J.
    Nachand, D.
    Steele, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I398 - I399
  • [27] Treatment of Crohn's-Related Rectovaginal Fistula With Allogeneic Expanded-Adipose Derived Stem Cells: A Phase I-IIa Clinical Trial
    Garcia-Arranz, Mariano
    Herreros, Maria Dolores
    Gonzalez-Gomez, Carolina
    de la Quintana, Paloma
    Guadalajara, Hector
    Georgiev-Hristov, Tihomir
    Trebol, Jacobo
    Garcia-Olmo, Damian
    STEM CELLS TRANSLATIONAL MEDICINE, 2016, 5 (11) : 1441 - 1446
  • [28] Long-Term Follow-Up of Crohn Disease Fistulas After Local Injections of Bone Marrow-Derived Mesenchymal Stem Cells
    Ciccocioppo, Rachele
    Gallia, Alessandra
    Sgarella, Adele
    Kruzliak, Peter
    Gobbi, Paolo G.
    Corazza, Gino Roberto
    MAYO CLINIC PROCEEDINGS, 2015, 90 (06) : 747 - 755
  • [29] Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial
    de la Portilla, F.
    Alba, F.
    Garcia-Olmo, D.
    Herrerias, J. M.
    Gonzalez, F. X.
    Galindo, A.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2013, 28 (03) : 313 - 323
  • [30] Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I/IIa clinical trial
    F. de la Portilla
    F. Alba
    D. García-Olmo
    J. M. Herrerías
    F. X. González
    A. Galindo
    International Journal of Colorectal Disease, 2013, 28 : 313 - 323
12345